acetylcysteine has been researched along with Thrombosis in 15 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (13.33) | 29.6817 |
| 2010's | 10 (66.67) | 24.3611 |
| 2020's | 3 (20.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, Y; Chi, Y; Dai, X; Dong, H; Fang, L; Fu, R; Ju, M; Li, H; Liu, W; Liu, X; Sun, T; Wang, W; Xue, F; Yang, R; Zhang, A; Zhang, L | 1 |
| Beyler, O; Demir, C | 1 |
| Brooks, S; Chang, X; Craver, BM; Fleischman, AG; Hoang, S; Lai, HY; Mendez Luque, LF; Ramanathan, G | 1 |
| Ali, C; Denis, CV; Diamond, SL; Gakuba, C; Gauberti, M; Herbig, BA; Lenting, PJ; Martinez de Lizarrondo, S; Repessé, Y; Touzé, E; Vivien, D | 1 |
| Lillicrap, D | 1 |
| Stokes, KY; Wang, B; Yee Aw, T | 1 |
| Breborowicz, A; Mackowiak, B; Sosinska-Zawierucha, P | 1 |
| Barnado, A; Crofford, LJ; Oates, JC | 1 |
| Aguirre, MA; Barbarroja, N; Collantes-Estevez, E; Cuadrado, MJ; Jimenez-Gomez, Y; López-Pedrera, C | 1 |
| Andrews, RK; Berndt, MC | 1 |
| Chen, J; Fu, X; Gushiken, FC; López, JA; Moake, JL; Ni, H; Nolasco, L; Reheman, A | 1 |
| Barrett, F; Gibson, KR; MacRury, SM; Megson, IL; Sharma, S; Winterburn, TJ | 1 |
| Aiba, A; Eto, K; Iwakura, Y; Kadono, T; Kadowaki, T; Kakuta, S; Kamiya, A; Manabe, I; Nagai, R; Nagasaki, M; Nakauchi, H; Nishimura, S; Ooehara, J; Otsu, M; Petrich, BG; Sato, S; Sugiura, S; Takayama, N; Urano, T; Yamashita, H | 1 |
| Blanco-Vaca, F; Cuquet, J; López, N; Mateo, J | 1 |
| Amer, J; Fibach, E; Zelig, O | 1 |
2 review(s) available for acetylcysteine and Thrombosis
| Article | Year |
|---|---|
At the Bedside: Neutrophil extracellular traps (NETs) as targets for biomarkers and therapies in autoimmune diseases.
Topics: Acetylcysteine; Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis; Antibodies, Monoclonal; Antimalarials; Apoptosis; Atherosclerosis; Autoantigens; Autoimmune Diseases; Biomarkers; Deoxyribonuclease I; Extracellular Traps; Female; Humans; Hydrolases; Immunosuppressive Agents; Interferon-alpha; Lupus Erythematosus, Systemic; Molecular Targeted Therapy; Neutrophils; Pregnancy; Pregnancy Complications; Protein Processing, Post-Translational; Protein-Arginine Deiminase Type 4; Protein-Arginine Deiminases; Thrombophilia; Thrombosis; Translational Research, Biomedical; Vitamin D | 2016 |
Oxidative stress in the pathogenesis of atherothrombosis associated with anti-phospholipid syndrome and systemic lupus erythematosus: new therapeutic approaches.
Topics: Acetylcysteine; Anticoagulants; Antioxidants; Antiphospholipid Syndrome; Atherosclerosis; Autoantibodies; beta 2-Glycoprotein I; Coagulants; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Inflammation; Lupus Erythematosus, Systemic; Mitochondrial Diseases; Oxidative Stress; Reactive Oxygen Species; Recurrence; Thrombosis; Ubiquinone | 2016 |
13 other study(ies) available for acetylcysteine and Thrombosis
| Article | Year |
|---|---|
Increased reactive oxygen species lead to overactivation of platelets in essential thrombocythemia.
Topics: Acetylcysteine; Animals; Blood Platelets; Janus Kinases; Mice; Reactive Oxygen Species; Signal Transduction; STAT Transcription Factors; Thrombocythemia, Essential; Thrombosis | 2023 |
Use of n-acetylcysteine therapy in patients with relapsed refractory thrombotic thrombocytopenic purpura.
Topics: Acetylcysteine; ADAMTS13 Protein; Anemia, Hemolytic; Humans; Plasma Exchange; Purpura, Thrombotic Thrombocytopenic; Thrombosis; von Willebrand Factor | 2023 |
N-acetylcysteine inhibits thrombosis in a murine model of myeloproliferative neoplasm.
Topics: Acetylcysteine; Animals; Humans; Male; Mice; Myeloproliferative Disorders; Thrombosis | 2020 |
Potent Thrombolytic Effect of
Topics: Acetylcysteine; Animals; Blood Platelets; Chlorides; Disease Models, Animal; Ferric Compounds; Fibrinolytic Agents; Infarction, Middle Cerebral Artery; Male; Mice; Platelet Aggregation; Ristocetin; Thromboembolism; Thrombosis; Tissue Plasminogen Activator; von Willebrand Factor | 2017 |
Thrombolytic Potential of
Topics: Acetylcysteine; Fibrinolysis; Fibrinolytic Agents; Humans; Thrombosis | 2017 |
N-acetylcysteine attenuates systemic platelet activation and cerebral vessel thrombosis in diabetes.
Topics: Acetylcysteine; Animals; Blood Platelets; Brain; Diabetes Mellitus, Type 1; Male; Mice, Inbred C57BL; Platelet Activation; Platelet Aggregation Inhibitors; Pyruvaldehyde; Streptozocin; Thrombosis | 2018 |
N-Acetylcysteine and Sulodexide Reduce the Prothrombotic Effect of Uremic Serum on the Venous Endothelial Cells.
Topics: Acetylcysteine; Anticoagulants; Blood Specimen Collection; Cells, Cultured; Endothelial Cells; Endothelium, Vascular; Female; Free Radical Scavengers; Glycosaminoglycans; Humans; Kidney Failure, Chronic; Male; Thrombosis; Uremia | 2019 |
Thrombotic thrombocytopenic purpura: reducing the risk?
Topics: Acetylcysteine; ADAM Proteins; ADAMTS13 Protein; Animals; Humans; Membrane Glycoproteins; Mice; Platelet Aggregation; Platelet Glycoprotein GPIb-IX Complex; Purpura, Thrombotic Thrombocytopenic; Thrombosis; von Willebrand Factor | 2011 |
N-acetylcysteine reduces the size and activity of von Willebrand factor in human plasma and mice.
Topics: Acetylcysteine; ADAMTS13 Protein; Animals; Anti-Bacterial Agents; Endothelial Cells; Humans; Male; Metalloendopeptidases; Mice; Mice, Inbred C57BL; Mice, Knockout; Plasma; Platelet Aggregation; Protein Multimerization; Purpura, Thrombotic Thrombocytopenic; Ristocetin; Thrombosis; von Willebrand Factor | 2011 |
Therapeutic potential of N-acetylcysteine as an antiplatelet agent in patients with type-2 diabetes.
Topics: Acetylcysteine; Adenosine Diphosphate; Diabetes Mellitus, Type 2; Dose-Response Relationship, Drug; Female; Glutathione; Humans; Male; Middle Aged; Nitric Oxide; Oxidative Stress; Platelet Aggregation; Platelet Aggregation Inhibitors; Platelet Function Tests; Reactive Oxygen Species; Thrombin; Thrombosis | 2011 |
In vivo imaging visualizes discoid platelet aggregations without endothelium disruption and implicates contribution of inflammatory cytokine and integrin signaling.
Topics: Acetylcysteine; Animals; Blood Platelets; Cells, Cultured; Endothelium, Vascular; Flow Cytometry; Human Umbilical Vein Endothelial Cells; Humans; Interleukin-1; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; Mice, Transgenic; Microscopy, Confocal; Platelet Aggregation; Platelet Glycoprotein GPIb-IX Complex; Platelet Glycoprotein GPIIb-IIIa Complex; Protein Binding; rac1 GTP-Binding Protein; Reactive Oxygen Species; Receptors, Tumor Necrosis Factor; Signal Transduction; Thrombosis; Tumor Necrosis Factor-alpha; von Willebrand Factor | 2012 |
Patient presenting multiple consecutive venous and arterial thrombotic events despite intensive conventional treatment: response after normalization of plasma homocysteine and N-acetylcysteine therapy.
Topics: Acetylcysteine; Fatal Outcome; Fibrinolytic Agents; Homocysteine; Humans; Male; Middle Aged; Pulmonary Embolism; Streptokinase; Thrombosis; Venous Thrombosis | 2003 |
Oxidative status of red blood cells, neutrophils, and platelets in paroxysmal nocturnal hemoglobinuria.
Topics: Acetylcysteine; Anemia; Antioxidants; Ascorbic Acid; Biomarkers; Blood Platelets; Erythrocytes; Female; Flow Cytometry; Hemoglobinuria, Paroxysmal; Humans; Hydrogen Peroxide; Male; Neutrophils; Oxidants; Oxidative Stress; Reference Values; Thrombosis; Tocopherols | 2008 |